These systems may take up to 5 hours to investigate a blood sample and require a different setting for different cancers types. The iChip, in comparison, can analyze a blood sample in under an full hour. They add that CTC recognition technologies will probably continue steadily to improve in sensitivity and for that reason that devices just like the iChip may eventually provide novel methods for early detection of invasive cancer before the establishment of metastatic disease. Licensed from medwireNews with permission from Springer Health care Ltd. All rights reserved. Neither of the parties endorse or recommend any commercial products, services, or equipment.. Cell sorting device improves recognition of circulating tumor cells By Lauretta Ihonor, medwireNews Reporter An automated cell sorting device developed in america may allow circulating tumor cells to be detected with better accuracy than by current methods, say researchers.Median length of hospital stay was 1 day longer for COPD patients than for non-COPD patients. ‘The use of evidence-structured therapies for all patients with AMI increased between 1997 and 2007,’ but this change did not affect clinical outcomes, say Stefan et al. They therefore conclude that ‘consideration is necessary to treat established cardiovascular risk elements and optimize cardiac therapies in patients with COPD.’ Certified from medwireNews with permission from Springer Healthcare Ltd. All rights reserved. Neither of the parties endorse or recommend any commercial products, services, or equipment.
Collaborative effort by FDA and EMEA expected to yield extra safety data when assessing new drugs In the first usage of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration and the European Medicines Agency worked collectively to allow drug companies to submit the benefits of seven new tests that assess kidney damage during animal studies of new drugs.